AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimwalf-M1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Walfs Pharma Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimwalf-M1 Tablet SR

Diabexe Duo SR tablets are a dual-action antidiabetic medication used to manage type 2 diabetes in adults. This combination therapy helps regulate blood glucose levels. Diabexe Duo SR should be taken with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can lead to elevated glucose levels, increasing the risk of complications such as renal impairment, vision loss, neuropathy, and limb amputation. This medication is one component of a comprehensive diabetes management plan, which includes a balanced diet, regular physical activity, and weight management as recommended by your doctor. Lifestyle modifications are vital for diabetes control. Hypoglycemia (low blood sugar) is the most frequent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential to mitigate this risk. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may also occur. Diabexe Duo SR is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their doctor before starting this medication. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Glimwalf-M1 Tablet SR

Managing type 2 diabetes

Major Benefits of Glimwalf-M1 Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimwalf-M1 Tablet SR should be administered with a meal.

Common Side effects of Glimwalf-M1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimwalf-M1 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimwalf-M1 Tablet SR should be administered with a meal.

How Glimwalf-M1 Tablet SR works:

Glimwalf-M1 SR tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness in the body.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimwalf-M1 Tablet SR and alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimwalf-M1 SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is recommended.

Breast feedingBreast feedingUNSAFE

Extended-release Glimwalf-M1 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Exercise caution when administering Glimwalf-M1 SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Glimwalf-M1 SR tablets are contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glimwalf-M1 Tablet SR to individuals with hepatic impairment. Dosage modification of Glimwalf-M1 Tablet SR may be necessary. Physician consultation is advised. Initiate Glimwalf-M1 Tablet SR therapy with a reduced dosage in patients exhibiting mild to moderate liver dysfunction; its use is contraindicated in those with severe liver disease.

What if you forget to take Glimwalf-M1 Tablet SR :

Should you forget to take a Glimwalf-M1 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimwalf-M1 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimwalf-M1 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication. Keep it out of reach of children, pets, and others.
Glimwalf-M1 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimwalf-M1 Tablet SR and seek immediate medical attention.
Glimwalf-M1 Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Glimwalf-M1 SR tablets may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis may also occur. Prolonged use can result in vitamin B12 deficiency.
Prolonged Glimwalf-M1 Tablet SR use can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues like tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, supplemental Vitamin B12 intake, at least annually, is recommended by some researchers.
Glimwalf-M1 SR tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimwalf-M1 Tablet SR and alcohol is unsafe. Alcohol can exacerbate the medication's blood sugar-lowering effect, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Glimwalf-M1 Tablet SR
54
MRP 63
14% off